U.S. flag

An official website of the United States government

NM_002617.4(PEX10):c.211del (p.Glu71fs) AND Peroxisome biogenesis disorder, complementation group 7

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 16, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003652319.2

Allele description [Variation Report for NM_002617.4(PEX10):c.211del (p.Glu71fs)]

NM_002617.4(PEX10):c.211del (p.Glu71fs)

Gene:
PEX10:peroxisomal biogenesis factor 10 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1p36.32
Genomic location:
Preferred name:
NM_002617.4(PEX10):c.211del (p.Glu71fs)
HGVS:
  • NC_000001.11:g.2408845del
  • NG_008342.1:g.8731del
  • NG_088790.1:g.264del
  • NM_001374425.1:c.211del
  • NM_001374426.1:c.-222del
  • NM_001374427.1:c.-222del
  • NM_002617.4:c.211delMANE SELECT
  • NM_153818.2:c.211del
  • NP_001361354.1:p.Glu71fs
  • NP_002608.1:p.Glu71fs
  • NP_722540.1:p.Glu71fs
  • NC_000001.10:g.2340280del
  • NC_000001.10:g.2340284del
  • NR_164636.1:n.330del
Protein change:
E71fs
Molecular consequence:
  • NM_001374426.1:c.-222del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001374427.1:c.-222del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001374425.1:c.211del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_002617.4:c.211del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_153818.2:c.211del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_164636.1:n.330del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Peroxisome biogenesis disorder, complementation group 7 (CG7)
Synonyms:
Peroxisome biogenesis disorder, complementation group B
Identifiers:
MedGen: C1864399

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004436954Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 16, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders.

Warren DS, Morrell JC, Moser HW, Valle D, Gould SJ.

Am J Hum Genet. 1998 Aug;63(2):347-59.

PubMed [citation]
PMID:
9683594
PMCID:
PMC1377304

Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients.

Warren DS, Wolfe BD, Gould SJ.

Hum Mutat. 2000;15(6):509-21.

PubMed [citation]
PMID:
10862081
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004436954.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Glu71Argfs*26) in the PEX10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX10 are known to be pathogenic (PMID: 9683594, 10862081, 21031596). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX10-related conditions. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024